Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.56%

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has an Asset Resilience Ratio of 5.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600332 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥4.62 Billion

≈ $676.64 Million USD Cash + Short-term Investments

Total Assets

CN¥83.17 Billion

≈ $12.17 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2024)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Asset Resilience Ratio has changed over time. See Guangzhou Baiyunshan Pharmaceutical Hold (600332) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Baiyunshan Pharmaceutical Hold (600332) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥4.62 Billion	5.56%
Total Liquid Assets	CN¥4.62 Billion	5.56%

Asset Resilience Insights

Limited Liquidity: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd maintains only 5.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	Medical Distribution	4.44%
Jointown Pharmaceutical Group Co Ltd SHG:600998	Medical Distribution	0.08%

Annual Asset Resilience Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2001–2024)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	12.48%	CN¥10.20 Billion ≈ $1.49 Billion	CN¥81.68 Billion ≈ $11.95 Billion	+11.51pp
2023-12-31	0.98%	CN¥766.40 Million ≈ $112.15 Million	CN¥78.59 Billion ≈ $11.50 Billion	+0.90pp
2022-12-31	0.08%	CN¥56.87 Million ≈ $8.32 Million	CN¥74.67 Billion ≈ $10.93 Billion	+0.07pp
2020-12-31	0.01%	CN¥4.00 Million ≈ $585.33K	CN¥59.76 Billion ≈ $8.74 Billion	-2.99pp
2018-12-31	3.00%	CN¥1.54 Billion ≈ $225.65 Million	CN¥51.48 Billion ≈ $7.53 Billion	+2.98pp
2017-12-31	0.02%	CN¥4.88 Million ≈ $713.37K	CN¥28.31 Billion ≈ $4.14 Billion	-0.01pp
2016-12-31	0.02%	CN¥6.03 Million ≈ $881.81K	CN¥25.90 Billion ≈ $3.79 Billion	-0.02pp
2015-12-31	0.04%	CN¥6.50 Million ≈ $951.12K	CN¥15.87 Billion ≈ $2.32 Billion	+0.01pp
2014-12-31	0.03%	CN¥4.69 Million ≈ $685.71K	CN¥14.21 Billion ≈ $2.08 Billion	+0.01pp
2013-12-31	0.03%	CN¥3.36 Million ≈ $492.06K	CN¥12.25 Billion ≈ $1.79 Billion	-0.02pp
2012-12-31	0.05%	CN¥2.88 Million ≈ $420.84K	CN¥6.24 Billion ≈ $912.43 Million	-0.02pp
2011-12-31	0.06%	CN¥3.13 Million ≈ $457.68K	CN¥4.85 Billion ≈ $709.89 Million	-0.20pp
2010-12-31	0.26%	CN¥11.67 Million ≈ $1.71 Million	CN¥4.48 Billion ≈ $655.07 Million	-0.48pp
2009-12-31	0.74%	CN¥31.33 Million ≈ $4.58 Million	CN¥4.22 Billion ≈ $617.88 Million	+0.67pp
2008-12-31	0.07%	CN¥3.01 Million ≈ $440.22K	CN¥4.13 Billion ≈ $604.48 Million	-0.02pp
2007-12-31	0.09%	CN¥5.51 Million ≈ $806.49K	CN¥6.21 Billion ≈ $908.27 Million	-0.13pp
2005-12-31	0.21%	CN¥10.90 Million ≈ $1.60 Million	CN¥5.10 Billion ≈ $746.01 Million	-0.14pp
2004-12-31	0.36%	CN¥18.56 Million ≈ $2.72 Million	CN¥5.18 Billion ≈ $758.42 Million	-0.69pp
2003-12-31	1.05%	CN¥49.50 Million ≈ $7.24 Million	CN¥4.71 Billion ≈ $688.79 Million	-0.41pp
2002-12-31	1.47%	CN¥61.19 Million ≈ $8.95 Million	CN¥4.17 Billion ≈ $610.67 Million	-0.37pp
2001-12-31	1.84%	CN¥67.99 Million ≈ $9.95 Million	CN¥3.70 Billion ≈ $541.02 Million	--

pp = percentage points

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution

Market Cap

$4.66 Billion

CN¥31.84 Billion CNY

Market Cap Rank

#3762 Global

#603 in China

Share Price

CN¥22.65

Change (1 day)

-0.96%

52-Week Range

CN¥22.29 - CN¥27.59

All Time High

CN¥41.57